IsoTherapeutics Group
Manufacturing · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1004 S Velasco St, Angleton, Texas, 7751...Phone Number
(979) 848-0800Website
www.isotherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About IsoTherapeutics Group
IsoTherapeutics is a commercial-stage company specializing in radiochemistry and bioconjugation development, offering contract manufacturing services to the radiopharmaceutical industry. With over 100 patents, they provide a range of services including radiopharmaceuticals, chelation, conjugation, and analytical studies. The company has state-of-the-art facilities located in Angleton, Texas, equipped for cGMP production and research. Recently acquired by Telix Pharmaceuticals, IsoTherapeutics enhances development capabilities and expands manufacturing infrastructure in the U.S.Explore more
IsoTherapeutics Group Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is IsoTherapeutics Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when IsoTherapeutics Group launches new products
Congratulate Masked Content for being promoted to Masked Content at IsoTherapeutics Group
Check if IsoTherapeutics Group has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
IsoTherapeutics Group, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if IsoTherapeutics Group is spiking on competitors!
Click to see if IsoTherapeutics Group had a recent Job posting/layoffs
Funding: Get notified immidiatlly once IsoTherapeutics Group has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on IsoTherapeutics Group recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined IsoTherapeutics Group as Masked Content
Find 2 more new buyers
Compare Similar Companies to IsoTherapeutics Group
Compare insights from companies similar to IsoTherapeutics Group, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
IsoTherapeutics Group is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
IsoTherapeutics Group is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about IsoTherapeutics Group.
IsoTherapeutics Group Tech Stack
A closer look at the technologies used by IsoTherapeutics Group
See more technologies
IsoTherapeutics Group News & Media
Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics
MELBOURNE, Australia, Feb. 27, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire IsoTherapeutics Group, LLC (IsoTherapeutics), a specialty radiopharmaceutical development and bioconjugation firm, based in Angleton, Texas. Founded in 2005, IsoTherapeutics is a privately held, commercial-stage company, which provides radiochemistry and bioconjugation development and contract manufacturing services to many cPlus Therapeutics Announces Two Significant Milestones Toward cGMP Manufacture of its Lead Investigational Radiotherapeutic
IsoTherapeutics Group LLC to develop and supply cGMP grade Rhenium-186 isotope for Plus Therapeutics’ Rhenium-186 NanoLiposome (186RNL) radiotherapeuticQSAM Biosciences Seeks to Expand Radiochemical Assets; Signs Option Agreement to License its Second Promising Cancer Therapy
Austin, Texas, March 17, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences, Inc. (OTCQB: QSAM) announced today that it has signed an Exclusive Option Agreement with IsoTherapeutics Group, LLC to allow the Company a 120-day period to perform diligence and negotiate a worldwide, exclusive license agreement for a pre-clinical staged radiochemical therapy called BetaBrach™.Monopar and NorthStar Partner with IsoTherapeutics for the Manufacturing of Potential Therapeutic for Severe COVID-19
WILMETTE, Ill. and BELOIT, Wis. and ANGLETON, Texas, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (Wilmette, IL) and NorthStar Medical Radioisotopes, LLC (Beloit, WI), who are collaborating on the development of Radio-Immuno-Therapeutics (RITs) to treat patients with severe COVID-19, today announced a partnership with IsoTherapeutics Group, LLC (Angleton, TX), to develop and manufacture a RIT for the potential treatment of severe COVID-19.
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding IsoTherapeutics Group
Sign Up For FreeTo access detailed company insights
IsoTherapeutics is a commercial-stage company specializing in radiochemistry and bioconjugation development, offering contract manufacturing services to the radiopharmaceutical industry. With over 100 patents, they provide a range of services including radiopharmaceuticals, chelation, conjugation, and analytical studies. The company has state-of-th... Read More
